Business

Microbix Has Best-Ever Quarterly Sales

Microbix Has Best-Ever Quarterly Sales

articleMicrobix Biosystems Inc.October 20, 20103/company/microbix-biosystems-inc/news/microbix-has-best-ever-quarterly-sales
Microbix Has Best-Ever Quarterly Sales

About this update from Microbix Biosystems Inc.

[{"type":"text","content":"\n\n\n\n Oct. 20, 2010 (Canada NewsWire Group) -- \n\n#ReleaseContent TABLE\n{\n BORDER-COLLAPSE: collapse\n}\nTR.cnwUnderlinedCell TD\n{\n BORDER-BOTTOM: #000000 1px solid\n}\nTR.cnwDoubleUnderlinedCell TD\n{\n BORDER-BOTTOM: #000000 3px double\n}\nTR.cnwBoldUnderlinedCell TD\n{\n BORDER-BOTTOM: #000000 3px solid\n}\nTD.cnwUnderlinedCell\n{\n BORDER-BOTTOM: #000000 1px solid\n}\nTD.cnwDoubleUnderlinedCell\n{\n BORDER-BOTTOM: #000000 3px double\n}\nTD.cnwBoldUnderlinedCell\n{\n BORDER-BOTTOM: #000000 3px solid\n}\n#ReleaseContent TABLE.cnwBorderedTable TD\n{\n BORDER-RIGHT: black 1px solid;\n PADDING-RIGHT: 2px;\n BORDER-TOP: black 1px solid;\n PADDING-LEFT: 2px;\n PADDING-BOTTOM: 2px;\n BORDER-LEFT: black 1px solid;\n PADDING-TOP: 2px;\n BORDER-BOTTOM: black 1px solid;\n BORDER-COLLAPSE: collapse\n}\n#ReleaseContent TABLE TD\n{\n PADDING-RIGHT: 2px;\n PADDING-LEFT: 2px;\n PADDING-BOTTOM: 2px;\n PADDING-TOP: 2px\n}\n\n\nToronto Biotech Company Also Expects a 15% Increase in Sales Volume for 2011  \n\n\nTORONTO, Oct. 20 /CNW/ - Microbix Biosystems Inc. (MBX:TSX), a\n biotechnology company focused on virology and biological technologies,\n reported strong worldwide sales of $1.9 million for the fourth quarter\n of 2010 ending September 30th (unaudited) fueled by a 15% increase in virology product volume and a\n 20% increase in demand for its pharmaceutical-grade water products.\n\n\nThis growth was driven by increased demand for Microbix' products\n following an increase in new diagnostic kit launches by its customers\n and Microbix' entry into the market for laboratory proficiency testing\n for viruses in clinical samples. In the quarter, Microbix also expanded\n into the pharmaceutical solutions market for formulating drugs, for\n which the Company expects significant growth. \n\n\nBased on the strong sales growth at the close of this fiscal year,\n Microbix projects a 15% increase in worldwide sales for 2011 based on\n current currency rates.\n\n\nWilliam J. Gastle, Microbix' Chief Executive Officer, said: "Our strong\n sales for the quarter and our projected 15% sales increase for next\n year are based on the Company's decision a few years ago to risk\n financing and building a new innovative production facility which more\n than tripled our manufacturing capacity. This new facility has allowed\n Microbix to pro...

More updates from Microbix Biosystems Inc.